CME/CE

CME/CE Courses


Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.


Featured Courses

How Should We Tackle Comorbid Obesity in T2DM? Applying New Strategies to Optimize Glycemic Control and Weight Management via Virtual Patient Simulation

Virtual Patient: Comorbid Obesity in T2DM | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
1.00 CME CNE: To enhance your ability to treat patients with these 2 highly prevalent conditions, we invite you to participate in this interactive CME series via 3 interactive patient simulations. Exp 12/9/23
The Impact of OSA-Related EDS on HRQoL: Time for a Wake-Up Call

The Impact of OSA-Related EDS on HRQoL | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), ABIM MOC Points, CE for Pharmacists, AAPA Category 1 CME Credit
0.50 CME CE: Case 1 of 3-part series provides insight into the extensive impact of OSA-related EDS on psychosocial functioning and HRQoL. Exp. 5/11/23
Treatment Decisions for Patients with HCV and CKD

Treatment Decisions for Patients with HCV and CKD | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), ABIM MOC Points, CE for Pharmacists, AAPA Category 1 CME Credit
0.50 CME CE: This CMEO BriefCase will introduce a complex HCV case involving a patient with HCV and chronic kidney disease. Exp 5/17/23

More

Manifestations of Gaucher Disease: Rare or Under-recognized? | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points
1.00 CME CE: Faculty discuss GD, including its less commonly reported manifestations, diagnostic pathways, and patient-centric multidisciplinary management of the disorder. Exp. 3/21/24

Improving Your OAB Care: A Focus on the Elderly and Male Patients | myCME

AMA PRA Category 1 Credit(s)TM, CE for Nurse Practitioner
Identify LUTS in male patients that may represent BPH, OAB, or a combination of both. Discuss recent data on therapeutic options to manage OAB-wet and OAB-dry patients. Individualize the management of elderly patients with OAB, considering medication burden, comorbidities, and cognitive status.

Maintenance Therapy in the Long-Term Management of AML | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists
1.50 CME CE: Live at ASH 2022, expert faculty discuss the use of maintenance therapy to improve long-term outcomes in AML and factors that contribute to disparities in care. Exp 1/23/24

The Patient Journey: Eliminating Disparities at Every Step | myCME

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s), CE for Pharmacists, AAPA Category 1 CME Credit, ABIM MOC Points, CE for Social Worker, CE for Case Manager, CE for Psychologist, CPEU Credit
1.50 CME CE: In this CMEO webcast, expert faculty will discuss unconscious bias, racial and ethnic disparities, and health inequities. Exp. 12/22/23

Precision Medicine in Rheumatoid Arthritis | myCME

AMA PRA Category 1 Credit(s)TM
0.50 CME: In this presentation, HSS Physician-in-Chief Dr. Louis Bridges discusses precision medicine in the care of rheumatoid arthritis and why it is needed, the treatment efficacy and toxicity in rheumatoid arthritis database and repository (TETRAD) study, the Accelerating Medicines Partnership (AMP) program, and future directions. 11/8/2025

Rheumatoid Arthritis and the Mucosal Origins Hypothesis | myCME

AMA PRA Category 1 Credit(s)TM
0.75 CME: Hear from Dr. V. Michael Holers as he discusses the SERA study on the multiple factors that drive the initiation and development of seropositive rheumatoid arthritis, including genetic risk, environmental risk factors, and systemic autoimmunity. 11/8/2025

JAK Inhibitors for Rheumatoid Arthritis: Where Are We? | myCME

AMA PRA Category 1 Credit(s)TM
0.75 CME: Hear from Dr. Stanley Cohen as he provides a comprehensive overview of janus kinase (JAK) inhibitors and their development over the years, including several studies on their safety and efficacy and current guidelines. 11/8/2025

Unraveling the Molecular Underpinnings of Rheumatoid Arthritis Symptoms | myCME

AMA PRA Category 1 Credit(s)TM
0.50 CME: This presentation highlights current efforts in rheumatology to investigate and understand the molecular underpinnings of symptoms of rheumatoid arthritis (RA), particularly flares of RA, morning stiffness, and synovial inflammation and pain, as well as the relationship between these. 11/8/2025